Cardioloxía

2017

1. 2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

   Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 162-171

2. A Brief History. Impact of the Advances in Ischaemic Heart Disease

   Revista Espanola de Cardiologia Suplementos, Vol. 17, pp. 2-6

3. A Mitral Heart Valve Prosthesis Hidden Under Perivalvular Pannus

   Annals of Thoracic Surgery, Vol. 103, Núm. 1, pp. e91

4. A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry

   Heart Rhythm, Vol. 14, Núm. 9, pp. 1375-1379

5. ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy

   Basic and Clinical Pharmacology and Toxicology, Vol. 120, Núm. 5, pp. 466-474

6. Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature

   JACC: Clinical Electrophysiology, Vol. 3, Núm. 3, pp. 253-265

7. Acute myocardial infarction due to left main embolization of calcified tissue from mitral valve subapparatus

   Journal of Cardiology Cases, Vol. 15, Núm. 6, pp. 194-196

8. Additive value of the CRUSADE score to the GRACE score for mortality risk prediction in patients with acute coronary syndromes

   International Journal of Cardiology, Vol. 245, pp. 1-5

9. Anemia at Hospital Admission and Its Relation to Outcomes in Patients With Heart Failure (from the Polish Cohort of 2 European Society of Cardiology Heart Failure Registries)

   American Journal of Cardiology, Vol. 119, Núm. 12, pp. 2021-2029

10. Angioplastia primaria en mayores de 75 años. Perfil de pacientes y procedimientos, resultados y predictores pronósticos en el registro ESTROFA IM + 75

    Revista Espanola de Cardiologia, Vol. 70, Núm. 2, pp. 81-87

11. Análisis Factorial Confirmatorio para medir las limitantes percibidas en el pregrado para el desarrollo de actividades de investigación

    Nova scientia, Vol. 9, Núm. 18, pp. 515-536

12. Association of cardiac resynchronization therapy with the incidence of appropriate implantable cardiac defibrillator therapies in ischaemic and non-ischaemic cardiomyopathy

    Europace, Vol. 19, Núm. 11, pp. 1818-1825

13. Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)

    International Journal of Cardiology, Vol. 243, pp. 516-522

14. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up

    Heart and Vessels, Vol. 32, Núm. 9, pp. 1077-1084

15. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention

    Journal of the American College of Cardiology, Vol. 69, Núm. 2, pp. 176-185

16. Características basales y manejo clínico de los primeros 3.000 pacientes incluidos en el estudio IBERICAN (Identificación de la población española de riesgo cardiovascular y renal)

    Semergen: revista española de medicina de familia, Núm. 7, pp. 493-500

17. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486

18. Cardiopatía isquémica crónica en el anciano

    Semergen: revista española de medicina de familia, Núm. 2, pp. 109-122

19. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

20. Characteristics of the Metabolic Syndrome in the Patients of IBERICAN Study (Identification of the Spanish Population at Cardiovascular and Renal Risk)

    Metabolic Syndrome and Related Disorders, Vol. 15, Núm. 9, pp. 431-438